Skip to main content

AGREGACION DE PROTEINAS: APLICACIONES BIOMEDICAS Y BIOTECNOLOGICAS

PID2019-105017RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 38
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Harnessing prion-inspired amyloid self-assembly for sustainable and biocompatible proton conductivity

  • Navarro, Susanna|||0000-0001-8160-9536
  • Andrio, Andreu|||0000-0003-2805-103X
  • Díaz-Caballero, Marta|||0000-0001-9032-9819
  • Ventura, Salvador|||0000-0002-9652-6351
  • Compañ, Vicente|||0000-0001-8233-7472
Protein-based materials have emerged as promising candidates for proton-conducting biomaterials. Therefore, drawing inspiration from the amino acid composition of prion-like domains, we designed short self-assembling peptides incorporating the (X-Tyr) motif, with X representing Asn, Gly and Ser, which form fibrillar structures capable of conducting protons. In this study, we conducted an analysis of the conductivity capacity of these fibers, with a focus on temperature and frequency dependence of conductivity. The loss tangent curves data and the electrode polarization model with the Debye approximation were employed to calculate transport properties, including conductivity, diffusivity, and density of charge carriers. Results revealed the prion-like fibers can transport protons more efficiently than biomaterials and other synthetic proton conducting materials, and that a significant increase in conductivity is observed with fibrillar orientations. The temperature dependence of conductivity of the peptides, measured in wet conditions, showed conductivities following the trend σ (NY7) < σ (GY7) < σ (SY7), in all the range of temperatures studied. The Arrhenius behavior, and the activation energy associated with conductivity followed the trend: E (SY7) = 8.2 ± 0.6 kJ mol -1 < E (GY7) < 13 ± 5 kJ mol -1 < E (NY7) = 31 ± 7 kJ mol -1, in different range of temperatures depending of the peptide. Furthermore, the diffusion coefficient correlated with increasing temperature in GY7 and SY7 fibers for temperatures compress between 20 °C and 80 °C, while NY7 only below 60 °C. However, it is noteworthy that the diffusivity observed in the SY7 peptide is lower, compared to GY7 and NY7 presumably due to its enlarged length. This observation can be attributed to two factors: firstly, the higher conductivity values observed in SY7 compared to GY7 and NY7, and secondly, to the value of relation observed of cations present in the peptide SY7 compared with GY7 and NY7, which in turn is dependent on temperature. In light of these findings, we envision our prion-inspired nanofibers as highly efficient proton-conducting natural biopolymers that are both biocompatible and biodegradable. These properties provide the opportunity for the development of next-generation bioelectrical interfaces and protonic devices.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

aSynPEP-DB, a database of biogenic peptides for inhibiting α-synuclein aggregation

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Manglano-Artuñedo, Zoe
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet effective treatments able to stop or delay disease progression remain elusive. The aggregation of a presynaptic protein, α-synuclein (aSyn), is the primary neurological hallmark of PD and, thus, a promising target for therapeutic intervention. However, the lack of consensus on the molecular properties required to specifically bind the toxic species formed during aSyn aggregation has hindered the development of therapeutic molecules. Recently, we defined and experimentally validated a peptide architecture that demonstrated high affinity and selectivity in binding to aSyn toxic oligomers and fibrils, effectively preventing aSyn pathogenic aggregation. Human peptides with such properties may have neuroprotective activities and hold a huge therapeutic interest. Driven by this idea, here, we developed a discriminative algorithm for the screening of human endogenous neuropeptides, antimicrobial peptides and diet-derived bioactive peptides with the potential to inhibit aSyn aggregation. We identified over 100 unique biogenic peptide candidates and ensembled a comprehensive database (aSynPEP-DB) that collects their physicochemical features, source datasets and additional therapeutic-relevant information, including their sites of expression and associated pathways. Besides, we provide access to the discriminative algorithm to extend its application to the screening of artificial peptides or new peptide datasets. aSynPEP-DB is a unique repository of peptides with the potential to modulate aSyn aggregation, serving as a platform for the identification of previously unexplored therapeutic agents. Database URL:.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A3D Model Organism Database (A3D-MODB), a database for proteome aggregation predictions in model organisms

  • Badaczewska-Dawid, Aleksandra E.
  • Kuriata, Aleksander
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Protein aggregation has been associated with aging and different pathologies and represents a bottleneck in the industrial production of biotherapeutics. Numerous past studies performed in Escherichia coli and other model organisms have allowed to dissect the biophysical principles underlying this process. This knowledge fuelled the development of computational tools, such as Aggrescan 3D (A3D) to forecast and re-design protein aggregation. Here, we present the A3D Model Organism Database (A3D-MODB) , a comprehensive resource for the study of structural protein aggregation in the proteomes of 12 key model species spanning distant biological clades. In addition to A3D predictions, this resource incorporates information useful for contextualizing protein aggregation, including membrane protein topology and structural model confidence, as an indirect reporter of protein disorder. The database is openly accessible without any need for registration. We foresee A3D-MOBD evolving into a central hub for conducting comprehensive, multi-species analyses of protein aggregation, fostering the development of protein-based solutions for medical, biotechnological, agricultural and industrial applications.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mutations in human prion-like domains, pathogenic but not always amyloidogenic

  • Bartolomé-Nafría, Andrea|||0000-0003-3114-1415
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Ventura, Salvador|||0000-0002-9652-6351
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are multifunctional proteins with integral roles in RNA metabolism and the regulation of alternative splicing. These proteins typically contain prion-like domains of low complexity (PrLDs or LCDs) that govern their assembly into either functional or pathological amyloid fibrils. To date, over 60 mutations targeting the LCDs of hnRNPs have been identified and associated with a spectrum of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer's disease (AD). The cryo-EM structures of pathological and functional fibrils formed by different hnRNPs have been recently elucidated, including those of hnRNPA1, hnRNPA2, hnRNPDL-2, TDP-43, and FUS. In this review, we discuss the structural features of these amyloid assemblies, placing particular emphasis on scrutinizing the impact of prevalent disease-associated mutations mapping within their LCDs. By performing systematic energy calculations, we reveal a prevailing trend of destabilizing effects induced by these mutations in the amyloid structure, challenging the traditionally assumed correlation between pathogenicity and amyloidogenic propensity. Understanding the molecular basis of this discrepancy might provide insights for developing targeted therapeutic strategies to combat hnRNP-associated diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structural information in therapeutic peptides, Emerging applications in biomedicine

  • Iglesias, Valentin|||0000-0002-6133-0869
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Burdukiewicz, Michał|||0000-0001-8926-582X
  • Ventura, Salvador|||0000-0002-9652-6351
Peptides are attracting a growing interest as therapeutic agents. This trend stems from their cost-effectiveness and reduced immunogenicity, compared to antibodies or recombinant proteins, but also from their ability to dock and interfere with large protein-protein interaction surfaces, and their higher specificity and better biocompatibility relative to organic molecules. Many tools have been developed to understand, predict, and engineer peptide function. However, most state-of-the-art approaches treat peptides only as linear entities and disregard their structural arrangement. Yet, structural details are critical for peptide properties such as solubility, stability, or binding affinities. Recent advances in peptide structure prediction have successfully addressed the scarcity of confidently determined peptide structures. This review will explore different therapeutic and biotechnological applications of peptides and their assemblies, emphasizing the importance of integrating structural information to advance these endeavors effectively.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Harnessing prion-inspired amyloid self-assembly for sustainable and biocompatible proton conductivity

  • Navarro, Susana
  • Andrio, A.
  • Diaz-Caballero, Marta
  • Ventura, Salvador
  • Compañ Moreno, Vicente|||0000-0001-8233-7472
[EN] Protein-based materials have emerged as promising candidates for proton-conducting biomaterials. Therefore, drawing inspiration from the amino acid composition of prion-like domains, we designed short self-assembling peptides incorporating the (X-Tyr) motif, with X representing Asn, Gly and Ser, which form fibrillar structures capable of conducting protons. In this study, we conducted an analysis of the conductivity capacity of these fibers, with a focus on temperature and frequency dependence of conductivity. The loss tangent curves data and the electrode polarization model with the Debye approximation were employed to calculate transport properties, including conductivity, diffusivity, and density of charge carriers. Results revealed the prion-like fibers can transport protons more efficiently than biomaterials and other synthetic proton conducting materials, and that a significant increase in conductivity is observed with fibrillar orientations. The temperature dependence of conductivity of the peptides, measured in wet conditions, showed conductivities following the trend sigma(NY7) < sigma(GY7) < sigma(SY7), in all the range of temperatures studied. The Arrhenius behavior, and the activation energy associated with conductivity followed the trend: E-act (SY7) = 8.2 +/- 0.6 kJ mol(-1) < E-act (GY7) < 13 +/- 5 kJ mol(-1) < E-act (NY7) = 31 +/- 7 kJ mol(-1), in different range of temperatures depending of the peptide. Furthermore, the diffusion coefficient correlated with increasing temperature in GY7 and SY7 fibers for temperatures compress between 20 degrees C and 80 degrees C, while NY7 only below 60 degrees C. However, it is noteworthy that the diffusivity observed in the SY7 peptide is lower, compared to GY7 and NY7 presumably due to its enlarged length. This observation can be attributed to two factors: firstly, the higher conductivity values observed in SY7 compared to GY7 and NY7, and secondly, to the value of relation observed of cations present in the peptide SY7 compared with GY7 and NY7, which in turn is dependent on temperature. In light of these findings, we envision our prion-inspired nanofibers as highly efficient proton-conducting natural biopolymers that are both biocompatible and biodegradable. These properties provide the opportunity for the development of next-generation bioelectrical interfaces and protonic devices., We want to acknowledge to Generalitat Valenciana (PROMETEO 2023. CIPROM/2022/03) by V. C., the Spanish Ministry of Science and Innovation by the project number PID 2019-107137 RB-C2, and PID2019-105017RB-I00 by S. V. and S. N.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

  • Santos, Jaime
  • Gracia, Pablo
  • Navarro, Susanna
  • Peña-Díaz, Samuel
  • Pujols, Jordi
  • Cremades, Nunilo
  • Pallarés, Irantzu
  • Ventura, Salvador
14 pags., 6 figs., α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson’s disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of α-helical peptides that bind to these α-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic α-synuclein species., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) BIO2016-78310-R and BIO2017-91475-EXP to S.V, by the Ministry of Science and Innovation (MICINN) PID2019-105017RB-I00 to S.V, by ICREA, ICREA-Academia 2015 to S.V. N.C. was supported by MINECO RYC-2012-12068, MINECO/FEDER, EU BFU2015-64119-P and MICIU/FEDER, EU PGC2018-096335-B-100. J.S. was supported by MICINN via a doctoral grant (FPU17/01157).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design, synthesis and structure-activity evaluation of novel 2-pyridone-based inhibitors of α-synuclein aggregation with potentially improved BBB permeability

  • Mahía Moros, Alejandro
  • Peña-Díaz, Samuel
  • Navarro, Susanna
  • Galano-Frutos, Juan J.
  • Pallarés, Irantzu
  • Pujols, Jordi
  • Díaz de Villegas, María D.
  • Gálvez, José A.
  • Ventura, Salvador
  • Sancho, Javier
The treatment of Parkinson’s disease (PD), the second most common neurodegenerative human disorder, continues to be symptomatic. Development of drugs able to stop or at least slowdown PD progression would benefit several million people worldwide. SynuClean-D is a low molecular weight 2-pyridone-based promising drug candidate that inhibits the aggregation of α-synuclein in human cultured cells and prevents degeneration of dopaminergic neurons in a Caenorhabditis elegans model of PD. Improving SynuClean-D pharmacokinetic/pharmacodynamic properties, performing structure/activity studies and testing its efficacy in mammalian models of PD requires the use of gr-amounts of the compound. However, not enough compound is on sale, and no synthetic route has been reported until now, which hampers the molecule progress towards clinical trials. To circumvent those problems, we describe here an efficient and economical route that enables the synthesis of SynuClean-D with good yields as well as the synthesis of SynuClean-D derivatives. Structure-activity comparison of the new compounds with SynuClean-D reveals the functional groups of the molecule that can be disposed of without activity loss and those that are crucial to interfere with α-synuclein aggregation. Several of the derivatives obtained retain the parent’s compound excellent in vitro anti-aggregative activity, without compromising its low toxicity. Computational predictions and preliminary testing indicate that the blood brain barrier (BBB) permeability of SynuClean-D is low. Importantly, several of the newly designed and obtained active derivatives are predicted to display good BBB permeability. The synthetic route developed here will facilitate their synthesis for BBB permeability determination and for efficacy testing in mammalian models of PD., This research was funded by Spanish Ministry of Science and Innovation (grants PID2019-107293GB-I00 to JS and PID2019-105017RB-I00 to SV), by Gobierno de Aragón, Spain (grants LMP30_18 and E45_20R to JS), by ICREA (ICREA-Academia 2015 to SV) and by “la Caixa” Banking Foundation, Spain (grant CaixaImpulse CI18-00019, to SV). AM was a recipient of a predoctoral FPU fellowship from the Spanish Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Arabidopsis metacaspase MC1 localizes in stress granules, clears protein aggregates, and delays senescence

  • Ruiz-Solani, Nerea
  • Salguero-Linares, José Manuel
  • Armengot, Laia
  • Santos, Jaime
  • Pallarès, Irantzu
  • Midden, Katarina P. van
  • Phukkan, Ujjal J.
  • Koyuncu, Seda
  • Borràs-Bisa, Júlia
  • Li, Liang
  • Popa, Crina
  • Eisele, Frederik
  • Eisele-Bürger, Anna Maria
  • Hill, S. M.
  • Gutiérrez-Beltrán, Emilio
  • Nyström, Thomas
  • Valls, Marc
  • Llamas, Ernesto
  • Vilchez, David
  • Klemenčič, Marina
  • Ventura, Salvador
  • Coll, Núria S.
Stress granules (SGs) are highly conserved cytoplasmic condensates that assemble in response to stress and contribute to maintaining protein homeostasis. These membraneless organelles are dynamic, disassembling once the stress is no longer present. Persistence of SGs due to mutations or chronic stress has been often related to age-dependent protein-misfolding diseases in animals. Here, we find that the metacaspase MC1 is dynamically recruited into SGs upon proteotoxic stress in Arabidopsis (Arabidopsis thaliana). Two predicted disordered regions, the prodomain and the 360 loop, mediate MC1 recruitment to and release from SGs. Importantly, we show that MC1 has the capacity to clear toxic protein aggregates in vivo and in vitro, acting as a disaggregase. Finally, we demonstrate that overexpressing MC1 delays senescence and this phenotype is dependent on the presence of the 360 loop and an intact catalytic domain. Together, our data indicate that MC1 regulates senescence through its recruitment into SGs and this function could potentially be linked to its remarkable protein aggregate-clearing activity., Research at CRAG was supported by grants PID2019-108595RB-I00 funded by MCIN/AEI/10.13039/501100011033 and AGL2016-78002-R funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” (to N.S.C. and M.V.); fellowship BES-2017-080210 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” (to J.S.-L.); FPU19/03778 funded by MU (o Ministerio de Universidades) (to N.R.-S.); by the “Severo Ochoa Programme for Centres of Excellence in R&D” (SEV-2015-0533 and CEX2019-000902-S funded by MCIN/AEI/10.13039/501100011033); by the grant PID2020-119737GA-I00 funded by the Ministerio de Ciencia e Innovacion (MCIN/AEI/10.13039/501100011033) (to E.G.-B); by the Spanish Ministry of Science and Innovation (MICINN) grant PID2019-105017RB-I00 (to S.V.), by ICREA, ICREA-Academia 2020 (to S.V); by the MICINN fellowship (FPU17/01157) (to J.S.); and by the CERCA Programme/Generalitat de Catalunya. L.A. is supported by a Maria Zambrano postdoctoral fellowship by de Ministerio de Universidades and the European Union—NextGenerationEU. This work was also funded by the Deutsche Forschungsgemeinschaft (DFG) Germany's Excellence Strategy (CECAD, EXC 2030-390661388 to D.V. and CEPAS EXC-2048/1–390686111 to E.L.) and the Else Kröner-Fresenius-Stiftung (2021-EKSE.95) (to D.V.). We also acknowledge support from COST Actions PROTEOSTASIS (BM1307) and ProteoCure (CA20113), supported by COST (European Cooperation in Science and Technology) (N.R.-S., U.P., L.L., and N.S.C). We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000902-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion

  • Santos, Jaime
  • Cuéllar, Jorge
  • Pallarès, Irantzu
  • Byrd, Emily J
  • Lends, Alons
  • Moro, Fernando
  • Abdul-Shukkoor, Muhammed Bilal
  • López-Pujol, Jordi
  • Velasco-Carneros, Lorea
  • Sobott, Frank
  • Otzen, Daniel E
  • Calabrese, Antonio N
  • Muga, Arturo
  • Pedersen, Jan Skov
  • Loquet, Antoine
  • Valpuesta, José M.
  • Radford, Sheena E
  • Ventura, Salvador
Oligomeric species populated during α-synuclein aggregation are considered key drivers of neurodegeneration in Parkinson's disease. However, the development of oligomer-targeting therapeutics is constrained by our limited knowledge of their structure and the molecular determinants driving their conversion to fibrils. Phenol-soluble modulin α3 (PSMα3) is a nanomolar peptide binder of α-synuclein oligomers that inhibits aggregation by blocking oligomer-to-fibril conversion. Here, we investigate the binding of PSMα3 to α-synuclein oligomers to discover the mechanistic basis of this protective activity. We find that PSMα3 selectively targets an α-synuclein N-terminal motif (residues 36-61) that populates a distinct conformation in the mono- and oligomeric states. This α-synuclein region plays a pivotal role in oligomer-to-fibril conversion as its absence renders the central NAC domain insufficient to prompt this structural transition. The hereditary mutation G51D, associated with early onset Parkinson's disease, causes a conformational fluctuation in this region, leading to delayed oligomer-to-fibril conversion and an accumulation of oligomers that are resistant to remodeling by molecular chaperones. Overall, our findings unveil a new targetable region in α-synuclein oligomers, advance our comprehension of oligomer-to-amyloid fibril conversion, and reveal a new facet of α-synuclein pathogenic mutations., The Spanish Ministry of Economy and Competitiveness (MINECO) grant BIO2017-91475-EXP (SV), the Spanish Ministry of Science and Innovation (MICINN) grants PID2019-105017RB-I00 (SV) and PID2022-137963OB-I00 (SV and IP), the MICINN grant PID2019-105872 GB-I00 (JMV) and PID2022-137175NB-I00 (JMV and JC), the MICINN grant PID2019-111068GB-I00 (AM) ICREA-Aca- demia 2015 (SV), the MICINN doctoral grant FPU17/01157 (JS), the Early postdoc mobility project SNSF P2EZP2_184258 (AL), the Basque Government grant IT1745-22 (FM), the BBSRC BB/M011151/1 grant (EJB), the Sir Henry Dale Fellowship jointly funded by Wellcome and the Royal Society 220628/Z/20/Z (ANC), the Royal Society grant RGS\R2\222357 (ANC), the University Academic Fellowship from the University of Leeds (ANC), and the Royal Society Research Professorship RSRP/R1/211057 (SER) are the funding sources., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein toxic oligomers

  • Giarola, Juliana Fátima
  • Santos, Jaime
  • Estévez, M. Carmen
  • Ventura, Salvador
  • Pallarès, Irantzu
  • Lechuga, Laura M.
[Background] α-Synuclein (αS) aggregation is the main neurological hallmark of a group of neurodegenerative disorders, collectively referred to as synucleinopathies, of which Parkinson's disease (PD) is the most prevalent. αS oligomers are elevated in the cerebrospinal fluid (CSF) of PD patients, standing as a biomarker for disease diagnosis. However, methods for early PD detection are still lacking. We have recently identified the amphipathic 22-residue peptide PSMα3 as a high-affinity binder of αS toxic oligomers. PSMα3 displayed excellent selectivity and reproducibility, binding to αS toxic oligomers with affinities in the low nanomolar range and without detectable cross-reactivity with functional monomeric αS., [Results] In this work, we leveraged these PSMα3 unique properties to design a plasmonic-based biosensor for the direct detection of toxic oligomers under label-free conditions., [Significance and novelty] We describe the integration of the peptide in a lab-on-a-chip plasmonic platform suitable for point-of-care measurements of αS toxic oligomers in CSF samples in real-time and at an affordable cost, providing an innovative biosensor for PD early diagnosis in the clinic., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) BIO2016-78310-R and BIO2017-91475-EXP to S.V, by the Ministry of Science and Innovation (MICINN) PID2019-105017RB-I00 to S.V, by ICREA, ICREA-Academia 2015 to S.V. J.S. was supported by MICINN via a doctoral grant (FPU17/01157). ICN2 is funded by the CERCA programme/Generalitat de Catalunya). The ICN2 is supported by Severo Ochoa Centres of Excellence programme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. The NanoB2A group is a consolidated research group (Grup de Recerca) of the Generalitat de Catalunya and has support from the Departament de Recerca i Universitats de la Generalitat de Catalunya (expedient: 2021 SGR 00456)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001214-S)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multifunctional antibody-conjugated coiled-coil protein nanoparticles for selective cell targeting

  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Ventura, Salvador|||0000-0002-9652-6351
Nanostructures decorated with antibodies (Abs) are applied in bioimaging and therapeutics. However, most covalent conjugation strategies affect Abs functionality. In this study, we aimed to create protein-based nanoparticles to which intact Abs can be attached through tight, specific, and noncovalent interactions. Initially considered waste products, bacterial inclusion bodies (IBs) have been used in biotechnology and biomedicine. However, the amyloid-like nature of IBs limits their functionality and raises safety concerns. To bypass these obstacles, we have recently developed highly functional α-helix-rich IBs exploiting the natural self-assembly capacity of coiled-coil domains. We used this approach to create spherical, submicrometric, biocompatible and fluorescent protein nanoparticles capable of capturing Abs with high affinity. We showed that these IBs can be exploited for Ab-directed cell targeting. Simultaneous decoration of the nanoparticles with two different Abs in a controllable ratio enabled the construction of a bispecific antibody mimic that redirected T lymphocytes specifically to cancer cells. Overall, we describe an easy and cost-effective strategy to produce multivalent, traceable protein nanostructures with the potential to be used for biomedical applications. Statement of significance: Functional inclusion bodies (IBs) are promising platforms for biomedical and biotechnological applications. These nanoparticles are usually sustained by amyloid-like interactions, which imposes some limitations on their use. In this work, we exploit the natural coiled-coil self-assembly properties to create highly functional, nonamyloid, and fluorescent IBs capable of capturing antibodies. These protein-based nanoparticles are successfully used to specifically and simultaneously target two unrelated cell types and bring them close together, becoming a technology with potential application in bioimaging and immunotherapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Functionalized Prion-Inspired Amyloids for Biosensor Applications

  • Díaz-Caballero, Marta|||0000-0001-9032-9819
  • Navarro, Susanna|||0000-0001-8160-9536
  • Ventura, Salvador|||0000-0002-9652-6351
Protein amyloid nanofibers provide a biocompatible platform for the development of functional nanomaterials. However, the functionalities generated up to date are still limited. Typical building blocks correspond to aggregation-prone proteins and peptides, which must be modified by complex and expensive reactions post-assembly. There is high interest in researching alternative strategies to tailor amyloid-based nanostructures' functionality on demand. In the present study, the biotin-streptavidin system was exploited for this purpose. Prion-inspired heptapeptides (Ac-NYNYNYN-NH, Ac-QYQYQYQ-NH, and Ac-SYSYSYS-NH) were doped with biotin-conjugated counterparts and assembled into amyloid-like fibers under mild conditions. The scaffolds' versatile functionalization was demonstrated by decorating them with different streptavidin conjugates, including gold nanoparticles, quantum dots, and enzymes. In particular, they were functionalized with peroxidase or phosphatase activities using streptavidin conjugated with horseradish peroxidase and alkaline phosphatase, respectively. Modification of amyloid-like nanostructures has generally been restricted to the addition of a single protein moiety. We functionalized the fibrils simultaneously with glucose oxidase and horseradish peroxidase, coupling these activities to build up a nanostructured glucose biosensor. Overall, we present a simple, modular, and multivalent approach for developing amyloid-based nanomaterials functionalized with any desired combination of chemical and biological moieties.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

DispHScan, a multi-sequence web tool for predicting protein disorder as a function of pH

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Uversky, Vladimir N.|||0000-0002-4037-5857
  • Ventura, Salvador|||0000-0002-9652-6351
Proteins are exposed to fluctuating environmental conditions in their cellular context and during their biotechnological production. Disordered regions are susceptible to these fluctuations and may experience solvent-dependent conformational switches that affect their local dynamism and activity. In a recent study, we modeled the influence of pH in the conformational state of IDPs by exploiting a charge-hydrophobicity diagram that considered the effect of solution pH on both variables. However, it was not possible to predict context-dependent transitions for multiple sequences, precluding proteome-wide analysis or the screening of collections of mutants. In this article, we present DispHScan, the first computational tool dedicated to predicting pH-induced disorder-order transitions in large protein datasets. The DispHScan web server allows the users to run pH-dependent disorder predictions of multiple sequences and identify context-dependent conformational transitions. It might provide new insights on the role of pH-modulated conditional disorder in the physiology and pathology of different organisms. The DispHScan web server is freely available for academic users, it is platform-independent and does not require previous registration.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Gracia González, Pablo
  • Navarro, Susanna|||0000-0001-8160-9536
  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Cremades, Nunilo|||0000-0002-9138-6687
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson's disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of α-helical peptides that bind to these α-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic α-synuclein species. α-Synuclein (αS) aggregation is a driver of several neurodegenerative disorders. Here, the authors identify a class of peptides that bind toxic αS oligomers and amyloid fibrils but not monomeric functional protein, and prevent further αS aggregation and associated cell damage.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Computational methods to predict protein aggregation

  • Navarro, Susanna|||0000-0001-8160-9536
  • Ventura, Salvador|||0000-0002-9652-6351
In most cases, protein aggregation stems from the establishment of non-native intermolecular contacts. The formation of insoluble protein aggregates is associated with many human diseases and is a major bottleneck for the industrial production of protein-based therapeutics. Strikingly, fibrillar aggregates are naturally exploited for structural scaffolding or to generate molecular switches and can be artificially engineered to build up multi-functional nanomaterials. Thus, there is a high interest in rationalizing and forecasting protein aggregation. Here, we review the available computational toolbox to predict protein aggregation propensities, identify sequential or structural aggregation-prone regions, evaluate the impact of mutations on aggregation or recognize prion-like domains. We discuss the strengths and limitations of these algorithms and how they can evolve in the next future.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Dual Antibody-Conjugated Amyloid Nanorods to Promote Selective Cell-Cell Interactions

  • Wang, Weiqiang|||0000-0002-6962-8811
  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Ventura, Salvador|||0000-0002-9652-6351
Grafting biomolecules on nanostructures' surfaces is an increasingly used strategy to target pathogenic cells, with both diagnostic and therapeutic applications. However, nanomaterials monofunctionalized by conjugating a single type of ligand find limited uses in pathologies/therapies that require two or more targets/receptors to be targeted and/or activated with a single molecular entity simultaneously. Therefore, multivalent nanomaterials for dual- or multitargeting are attracting significant interest. This study provides a proof of concept of such nanostructures. We have recently developed a modular methodology that allows obtaining amyloid-based materials decorated with active globular domains. Here, this approach is exploited to generate functional amyloid fibrils displaying antibody capture moieties. A high antibody binding affinity and capacity for the resulting nanofibrils, whose size can be manipulated to obtain homogeneous nanorods with high biocompatibility, are demonstrated. These nanorods are then used for specific antibody-mediated targeting of different cell types. Simultaneous conjugation of these nanorods with different antibodies allows obtaining a mimic of a bispecific antibody that redirects T lymphocytes to tumoral cells, holding high potential for immunotherapy. Overall, the work illustrates a modular and straightforward strategy to obtain preparative quantities of multivalent antibody-functionalized nanomaterials with multitargeting properties without the need for covalent modification.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains

  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Vasili, Eftychia
  • Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Manglano-Artuñedo, Zoe
  • Outeiro, Tiago Fleming
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, as well as the accumulation of intraneuronal proteinaceous inclusions known as Lewy bodies and Lewy neurites. The major protein component of Lewy inclusions is the intrinsically disordered protein α-synuclein (α-Syn), which can adopt diverse amyloid structures. Different conformational strains of α-Syn have been proposed to be related to the onset of distinct synucleinopathies; however, how specific amyloid fibrils cause distinctive pathological traits is not clear. Here, we generated three different α-Syn amyloid conformations at different pH and salt concentrations and analyzed the activity of SynuClean-D (SC-D), a small aromatic molecule, on these strains. We show that incubation of α-Syn with SC-D reduced the formation of aggregates and the seeded polymerization of α-Syn in all cases. Moreover, we found that SC-D exhibited a general fibril disaggregation activity. Finally, we demonstrate that treatment with SC-D also reduced strain-specific intracellular accumulation of phosphorylated α-Syn inclusions. Taken together, we conclude that SC-D may be a promising hit compound to inhibit polymorphic α-Syn aggregation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In-Silico Analysis of pH-Dependent Liquid-Liquid Phase Separation in Intrinsically Disordered Proteins

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Ventura, Salvador|||0000-0002-9652-6351
Intrinsically disordered proteins (IDPs) are essential players in the assembly of biomolecular condensates during liquid-liquid phase separation (LLPS). Disordered regions (IDRs) are significantly exposed to the solvent and, therefore, highly influenced by fluctuations in the microenvironment. Extrinsic factors, such as pH, modify the solubility and disorder state of IDPs, which in turn may impact the formation of liquid condensates. However, little attention has been paid to how the solution pH influences LLPS, despite knowing that this process is context-dependent. Here, we have conducted a large-scale in-silico analysis of pH-dependent solubility and disorder in IDRs known to be involved in LLPS (LLPS-DRs). We found that LLPS-DRs present maximum solubility around physiological pH, where LLPS often occurs, and identified significant differences in solubility and disorder between proteins that can phase-separate by themselves or those that require a partner. We also analyzed the effect of mutations in the resulting solubility profiles of LLPS-DRs and discussed how, as a general trend, LLPS-DRs display physicochemical properties that permit their LLPS at physiologically relevant pHs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of a highly potent transthyretin amyloidogenesis inhibitor, design, synthesis, and evaluation

  • Garcia de Carvalho Pinheiro, Francisca|||0000-0003-3778-1528
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Peccati, Francesca|||0000-0002-7813-8216
  • Sánchez-Morales, Adrià|||0000-0002-8692-0988
  • Varejão, Nathalia|||0000-0002-6952-8896
  • Bezerra, Filipa|||0000-0002-1675-2317
  • Ortega-Alarcon, David|||0000-0003-1885-4365
  • González, Danilo|||0000-0002-2316-2016
  • Osorio, Marcelo
  • Navarro, Susanna|||0000-0001-8160-9536
  • Velázquez-Campoy, Adrián|||0000-0001-5702-4538
  • Almeida, Maria Rosário|||0000-0001-9289-3835
  • Reverter Cendrós, David|||0000-0002-5347-0992
  • Busqué, Félix|||0000-0001-7566-4264
  • Alibés, Ramon|||0000-0002-7997-2691
  • Sodupe, Mariona|||0000-0003-0276-0524
  • Ventura, Salvador|||0000-0002-9652-6351
Transthyretin amyloidosis (ATTR) is a group of fatal diseases described by the misfolding and amyloid deposition of transthyretin (TTR). Discovering small molecules that bind and stabilize the TTR tetramer, preventing its dissociation and subsequent aggregation, is a therapeutic strategy for these pathologies. Departing from the crystal structure of TTR in complex with tolcapone, a potent binder in clinical trials for ATTR, we combined rational design and molecular dynamics (MD) simulations to generate a series of novel halogenated kinetic stabilizers. Among them, M-23 displays one of the highest affinities for TTR described so far. The TTR/ M-23 crystal structure confirmed the formation of unprecedented protein-ligand contacts, as predicted by MD simulations, leading to an enhanced tetramer stability both in vitro and in whole serum. We demonstrate that MD-assisted design of TTR ligands constitutes a new avenue for discovering molecules that, like M-23, hold the potential to become highly potent drugs to treat ATTR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The dynamic landscape of peptide activity prediction

  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Sidorczuk, Katarzyna|||0000-0001-6576-9054
  • Teufel, Felix
  • Nielsen, Henrik
  • Ventura, Salvador|||0000-0002-9652-6351
  • Burdukiewicz, Michał|||0000-0001-8926-582X
Peptides are known to possess a plethora of beneficial properties and activities: antimicrobial, anticancer, anti-inflammatory or the ability to cross the blood-brain barrier are only a few examples of their functional diversity. For this reason, bioinformaticians are constantly developing and upgrading models to predict their activity in silico, generating a steadily increasing number of available tools. Although these efforts have provided fruitful outcomes in the field, the vast and diverse amount of resources for peptide prediction can turn a simple prediction into an overwhelming searching process to find the optimal tool. This minireview aims at providing a systematic and accessible analysis of the complex ecosystem of peptide activity prediction, showcasing the variability of existing models for peptide assessment, their domain specialization and popularity. Moreover, we also assess the reproducibility of such bioinformatics tools and describe tendencies observed in their development. The list of tools is available under.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cryo-EM structure of hnRNPDL-2 fibrils, a functional amyloid associated with limb-girdle muscular dystrophy D3

  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Bartolomé-Nafría, Andrea|||0000-0003-3114-1415
  • Chaves-Sanjuan, Antonio|||0000-0003-3287-9024
  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Visentin, Cristina|||0000-0003-2705-1417
  • Bolognesi, Martino|||0000-0002-9253-5170
  • Ricagno, Stefano|||0000-0001-6678-5873
  • Ventura, Salvador|||0000-0002-9652-6351
hnRNPDL is a ribonucleoprotein (RNP) involved in transcription and RNA-processing that hosts missense mutations causing limb-girdle muscular dystrophy D3 (LGMD D3). Mammalian-specific alternative splicing (AS) renders three natural isoforms, hnRNPDL-2 being predominant in humans. We present the cryo-electron microscopy structure of full-length hnRNPDL-2 amyloid fibrils, which are stable, non-toxic, and bind nucleic acids. The high-resolution amyloid core consists of a single Gly/Tyr-rich and highly hydrophilic filament containing internal water channels. The RNA binding domains are located as a solenoidal coat around the core. The architecture and activity of hnRNPDL-2 fibrils are reminiscent of functional amyloids, our results suggesting that LGMD D3 might be a loss-of-function disease associated with impaired fibrillation. Strikingly, the fibril core matches exon 6, absent in the soluble hnRNPDL-3 isoform. This provides structural evidence for AS controlling hnRNPDL assembly by precisely including/skipping an amyloid exon, a mechanism that holds the potential to generate functional diversity in RNPs. The authors report the Cryo-EM of hnRNPDL-2 fibrils. The structure highlights features of a functional amyloid associated with limb-girdle muscular dystrophy-3 and explains how alternative splicing controls the assembly of this ribonucleoprotein.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring cryptic amyloidogenic regions in prion-like proteins from plants

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Manglano-Artuñedo, Zoe
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
Prion-like domains (PrLDs) are intrinsically disordered regions (IDRs) of low sequence complexity with a similar composition to yeast prion domains. PrLDs-containing proteins have been involved in different organisms' regulatory processes. Regions of moderate amyloid propensity within IDRs have been shown to assemble autonomously into amyloid fibrils. These sequences tend to be rich in polar amino acids and often escape from the detection of classical bioinformatics screenings that look for highly aggregation-prone hydrophobic sequence stretches. We defined them as cryptic amyloidogenic regions (CARs) and recently developed an integrated database that collects thousands of predicted CARs in IDRs. CARs seem to be evolutionary conserved among disordered regions because of their potential to stablish functional contacts with other biomolecules. Here we have focused on identifying and characterizing CARs in prion-like proteins (pCARs) from plants, a lineage that has been poorly studied in comparison with other prionomes. We confirmed the intrinsic amyloid potential for a selected pCAR from Arabidopsis thaliana and explored functional enrichments and compositional bias of pCARs in plant prion-like proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

SGnn, A Web Server for the Prediction of Prion-Like Domains Recruitment to Stress Granules Upon Heat Stress

  • Iglesias, Valentin|||0000-0002-6133-0869
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Santos-Suárez, Juan|||0000-0001-9360-2411
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Ventura, Salvador|||0000-0002-9652-6351
Proteins bearing prion-like domains (PrLDs) are essential players in stress granules (SG) assembly. Analysis of data on heat stress-induced recruitment of yeast PrLDs to SG suggests that this propensity might be connected with three defined protein biophysical features: aggregation propensity, net charge, and the presence of free cysteines. These three properties can be read directly in the PrLDs sequences, and their combination allows to predict protein recruitment to SG under heat stress. On this basis, we implemented SGnn, an online predictor of SG recruitment that exploits a feed-forward neural network for high accuracy classification of the assembly behavior of PrLDs. The simplicity and precision of our strategy should allow its implementation to identify heat stress-induced SG-forming proteins in complete proteomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Coiled-Coil Based Inclusion Bodies and Their Potential Applications

  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Ventura, Salvador|||0000-0002-9652-6351
The production of recombinant proteins using microbial cell factories is frequently associated with the formation of inclusion bodies (IBs). These proteinaceous entities can be sometimes a reservoir of stable and active protein, might display good biocompatibility, and are produced efficiently and cost-effectively. Thus, these submicrometric particles are increasingly exploited as functional biomaterials for biotechnological and biomedical purposes. The fusion of aggregation-prone sequences to the target protein is a successful strategy to sequester soluble recombinant polypeptides into IBs. Traditionally, the use of these IB-tags results in the formation of amyloid-like scaffolds where the protein of interest is trapped. This amyloid conformation might compromise the protein's activity and be potentially cytotoxic. One promising alternative to overcome these limitations exploits the coiled-coil fold, composed of two or more α-helices and widely used by nature to create supramolecular assemblies. In this review, we summarize the state-of-the-art of functional IBs technology, focusing on the coiled-coil-assembly strategy, describing its advantages and applications, delving into future developments and necessary improvements in the field.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decoding the role of coiled-coil motifs in human prion-like proteins

  • Behbahanipour, Molood|||0000-0002-7889-6105
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Ventura, Salvador|||0000-0002-9652-6351
Prions are self-propagating proteins that cause fatal neurodegenerative diseases in humans. However, increasing evidence suggests that eukaryotic cells exploit prion conformational conversion for functional purposes. A recent study delineated a group of twenty prion-like proteins in humans, characterized by the presence of low-complexity glutamine-rich sequences with overlapping coiled-coil (CCs) motifs. This is the case of Mediator complex subunit 15 (MED15), which is overexpressed in a wide range of human cancers. Biophysical studies demonstrated that the prion-like domain (PrLD) of MED15 forms homodimers in solution, sustained by CCs interactions. Furthermore, the same coiled-coil (CC) region plays a crucial role in the PrLD structural transition to a transmissible β-sheet amyloid state. In this review, we discuss the role of CCs motifs and their contribution to amyloid transitions in human prion-like domains (PrLDs), while providing a comprehensive overview of six predicted human prion-like proteins involved in transcription, gene expression, or DNA damage response and associated with human disease, whose PrLDs contain or overlap with CCs sequences. Finally, we try to rationalize how these molecular signatures might relate to both their function and involvement in disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

OligoBinders, Bioengineered Soluble Amyloid-like Nanoparticles to Bind and Neutralize SARS-CoV-2

  • Behbahanipour, Molood|||0000-0002-7889-6105
  • Benoit, Roger|||0000-0001-9420-7739
  • Navarro, Susanna|||0000-0001-8160-9536
  • Ventura, Salvador|||0000-0002-9652-6351
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a primary health concern. Molecules that prevent viral entry into host cells by interfering with the interaction between SARS-CoV-2 spike (S) protein and the human angiotensin-converting enzyme 2 receptor (ACE2r) opened a promising avenue for virus neutralization. Here, we aimed to create a novel kind of nanoparticle that can neutralize SARS-CoV-2. To this purpose, we exploited a modular self-assembly strategy to engineer OligoBinders, soluble oligomeric nanoparticles decorated with two miniproteins previously described to bind to the S protein receptor binding domain (RBD) with high affinity. The multivalent nanostructures compete with the RBD-ACE2r interaction and neutralize SARS-CoV-2 virus-like particles (SC2-VLPs) with IC values in the pM range, preventing SC2-VLPs fusion with the membrane of ACE2r-expressing cells. Moreover, OligoBinders are biocompatible and significantly stable in plasma. Overall, we describe a novel protein-based nanotechnology that might find application in SARS-CoV-2 therapeutics and diagnostics.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of Small Molecules Targeting α-Synuclein Aggregation, A Promising Strategy to Treat Parkinson's Disease

  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Ventura, Salvador|||0000-0002-9652-6351
Parkinson's disease, the second most common neurodegenerative disorder worldwide, is characterized by the accumulation of protein deposits in the dopaminergic neurons. These deposits are primarily composed of aggregated forms of α-Synuclein (α-Syn). Despite the extensive research on this disease, only symptomatic treatments are currently available. However, in recent years, several compounds, mainly of an aromatic character, targeting α-Syn self-assembly and amyloid formation have been identified. These compounds, discovered by different approaches, are chemically diverse and exhibit a plethora of mechanisms of action. This work aims to provide a historical overview of the physiopathology and molecular aspects associated with Parkinson's disease and the current trends in small compound development to target α-Syn aggregation. Although these molecules are still under development, they constitute an important step toward discovering effective anti-aggregational therapies for Parkinson's disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Amyloid Fibrils Formed by Short Prion-Inspired Peptides Are Metalloenzymes

  • Navarro, Susanna|||0000-0001-8160-9536
  • Díaz-Caballero, Marta|||0000-0001-9032-9819
  • Peccati, Francesca|||0000-0002-7813-8216
  • Roldán-Martín, Lorena|||0000-0002-6902-8285
  • Sodupe, Mariona|||0000-0003-0276-0524
  • Ventura, Salvador|||0000-0002-9652-6351
Enzymes typically fold into defined 3D protein structures exhibiting a high catalytic efficiency and selectivity. It has been proposed that the earliest enzymes may have arisen from the self-assembly of short peptides into supramolecular amyloid-like structures. Several artificial amyloids have been shown to display catalytic activity while offering advantages over natural enzymes in terms of modularity, flexibility, stability, and reusability. Hydrolases, especially esterases, are the most common artificial amyloid-like nanozymes with some reported to act as carbonic anhydrases (CA). Their hydrolytic activity is often dependent on the binding of metallic cofactors through a coordination triad composed of His residues in the β-strands, which mimic the arrangement found in natural metalloenzymes. Tyr residues contribute to the coordination of metal ions in the active center of metalloproteins; however, their use has been mostly neglected in the design of metal-containing amyloid-based nanozymes. We recently reported that four different polar prion-inspired heptapeptides spontaneously self-assembled into amyloid fibrils. Their sequences lack His but contain three alternate Tyr residues exposed to solvent. We combine experiments and simulations to demonstrate that the amyloid fibrils formed by these peptides can efficiently coordinate and retain different divalent metal cations, functioning as both metal scavengers and nanozymes. The metallized fibrils exhibit esterase and CA activities without the need for a histidine triad. These findings highlight the functional versatility of prion-inspired peptide assemblies and provide a new sequential context for the creation of artificial metalloenzymes. Furthermore, our data support amyloid-like structures acting as ancestral catalysts at the origin of life.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Arabidopsis metacaspase MC1 localizes in stress granules, clears protein aggregates, and delays senescence

  • Ruiz Solaní, Nerea|||0000-0002-0813-0956
  • Salguero Linares, Jose|||0000-0003-0559-7793
  • Armengot, Laia|||0000-0002-3790-9838
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • van Midden, Katarina P.|||0000-0002-4962-5410
  • Phukan, Ujjal Jyoti|||0000-0001-9788-4938
  • Koyuncu, Seda|||0000-0001-7937-3974
  • Borràs-Bisa, Júlia
  • Li, Liang
  • Popa, Crina|||0000-0002-4294-9949
  • Eisele, Frederik|||0000-0001-9995-5816
  • Eisele-Bürger, Anna Maria|||0000-0002-4009-094X
  • Hill, Sandra Malgrem|||0000-0001-7969-097X
  • Gutiérrez-Beltrán, Emilio|||0000-0001-7978-3164
  • Nyström, Thomas|||0000-0001-5489-2903
  • Valls, Marc|||0000-0003-2312-0091
  • Llamas, Ernesto|||0000-0001-9262-2402
  • Vilchez, David|||0000-0002-0801-0743
  • Klemenčič, Marina|||0000-0002-3079-4492
  • Ventura, Salvador|||0000-0002-9652-6351
  • Sánchez Coll, Núria|||0000-0002-8889-0399
Stress granules (SGs) are highly conserved cytoplasmic condensates that assemble in response to stress and contribute to maintaining protein homeostasis. These membraneless organelles are dynamic, disassembling once the stress is no longer present. Persistence of SGs due to mutations or chronic stress has been often related to age-dependent protein-misfolding diseases in animals. Here, we find that the metacaspase MC1 is dynamically recruited into SGs upon proteotoxic stress in Arabidopsis (Arabidopsis thaliana). Two predicted disordered regions, the prodomain and the 360 loop, mediate MC1 recruitment to and release from SGs. Importantly, we show that MC1 has the capacity to clear toxic protein aggregates in vivo and in vitro, acting as a disaggregase. Finally, we demonstrate that overexpressing MC1 delays senescence and this phenotype is dependent on the presence of the 360 loop and an intact catalytic domain. Together, our data indicate that MC1 regulates senescence through its recruitment into SGs and this function could potentially be linked to its remarkable protein aggregate-clearing activity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A3DyDB, exploring structural aggregation propensities in the yeast proteome

  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Badaczewska-Dawid, Aleksandra E.
  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Kuriata, Aleksander
  • Kmiecik, Sebastian|||0000-0001-7623-0935
  • Ventura, Salvador|||0000-0002-9652-6351
Background: The budding yeast Saccharomyces cerevisiae (S. cerevisiae) is a well-established model system for studying protein aggregation due to the conservation of essential cellular structures and pathways found across eukaryotes. However, limited structural knowledge of its proteome has prevented a deeper understanding of yeast functionalities, interactions, and aggregation. Results: In this study, we introduce the A3D yeast database (A3DyDB), which offers an extensive catalog of aggregation propensity predictions for the S. cerevisiae proteome. We used Aggrescan 3D (A3D) and the newly released protein models from AlphaFold2 (AF2) to compute the structure-based aggregation predictions for 6039 yeast proteins. The A3D algorithm exploits the information from 3D protein structures to calculate their intrinsic aggregation propensities. To facilitate simple and intuitive data analysis, A3DyDB provides a user-friendly interface for querying, browsing, and visualizing information on aggregation predictions from yeast protein structures. The A3DyDB also allows for the evaluation of the influence of natural or engineered mutations on protein stability and solubility. The A3DyDB is freely available at http://biocomp.chem.uw.edu.pl/A3D2/yeast. Conclusion: The A3DyDB addresses a gap in yeast resources by facilitating the exploration of correlations between structural aggregation propensity and diverse protein properties at the proteome level. We anticipate that this comprehensive database will become a standard tool in the modeling of protein aggregation and its implications in budding yeast.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Small molecules to target tau amyloid aggregation

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Review of Fifteen Years Developing Computational Tools to Study Protein Aggregation

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Bartolomé-Nafría, Andrea|||0000-0003-3114-1415
  • Fornt Suñé, Marc|||0000-0003-1197-2836
  • Iglesias, Valentin|||0000-0002-6133-0869
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Ventura, Salvador|||0000-0002-9652-6351
The presence of insoluble protein deposits in tissues and organs is a hallmark of many human pathologies. In addition, the formation of protein aggregates is considered one of the main bottlenecks to producing protein-based therapeutics. Thus, there is a high interest in rationalizing and predicting protein aggregation. For almost two decades, our laboratory has been working to provide solutions for these needs. We have traditionally combined the core tenets of both bioinformatics and wet lab biophysics to develop algorithms and databases to study protein aggregation and its functional implications. Here, we review the computational toolbox developed by our lab, including programs for identifying sequential or structural aggregation-prone regions at the individual protein and proteome levels, engineering protein solubility, finding and evaluating prion-like domains, studying disorder-to-order protein transitions, or categorizing non-conventional amyloid regions of polar nature, among others. In perspective, the succession of the tools we describe illustrates how our understanding of the protein aggregation phenomenon has evolved over the last fifteen years.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

A glimpse into the structural properties of α-synuclein oligomers

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
α-Synuclein (αS) aggregation is the main neurological hallmark of a group of debilitating neurodegenerative disorders, collectively referred to as synucleinopathies, of which Parkinson's disease is the most prevalent. αS oligomers formed during the initial stages of aggregation are considered key pathogenic drivers of disease onset and progression, standing as privileged targets for therapeutic intervention and diagnosis. However, the structure of αS oligomers and the mechanistic basis of oligomer to fibril conversion are yet poorly understood, thereby precluding the rational formulation of strategies aimed at targeting oligomeric species. In this review, we delve into the recent advances in the structural and mechanistic characterization of αS oligomers. We also discuss how these advances are transforming our understanding of these elusive species and paving the way for oligomer-targeting therapeutics and diagnosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Protein-only Nanoparticles for T Cell Expansion and Activation

  • Fornt Suñé, Marc|||0000-0003-1197-2836
  • Lázaro, Gonzalo|||0000-0002-7548-114X
  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Aran, Andrea|||0000-0002-9036-2085
  • Garcia-Pardo, Javier|||0000-0001-9179-6371
  • Martí, Mercè|||0000-0002-1846-0043
  • Ventura, Salvador|||0000-0002-9652-6351
The in vitro expansion and activation of T cells utilizing synthetic nanosized artificial antigen presenting cells (aAPCs) have emerged as a promising technique for cancer treatment. Although diverse nanomaterials have been explored as aAPC scaffolds, protein-only nanoparticles have been largely overlooked, despite their high designability and biocompatibility. In this study, we exploit a plug-and-play approach for the development of protein-only nanoparticles as aAPCs using the self-assembling properties of ZapB coiled coil and the Z-domain antibody-capturing ability. The resulting coiled coil-based nanoparticles (ccNPs) can be easily, rapidly, and simultaneously functionalized with anti-CD3 and anti-CD28 antibodies (ccNPs-CD3/CD28). Our results demonstrate that ccNPs-CD3/CD28 induce polyclonal T cell proliferation and activation while sustaining cytokine production for an extended period. The biocompatibility, modularity, and chemistry-free surface modification of this protein-only strategy render it a versatile platform for in vitro T cell expansion and activation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Cuéllar, Jorge|||0000-0002-7789-807X
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Byrd, Emily|||0000-0002-9876-1400
  • Lends, Alons
  • Moro, Fernando
  • Abdul-Shukkoor, Muhammed Bilal
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Velasco-Carneros, Lorea|||0000-0002-1296-9498
  • Sobott, Frank|||0000-0001-9029-1865
  • Otzen, Daniel E.|||0000-0002-2918-8989
  • Calabrese, Antonio N.|||0000-0003-2437-7761
  • Muga, Arturo|||0000-0003-0345-6882
  • Pedersen, Jan Skov|||0000-0002-7768-0206
  • Loquet, Antoine|||0000-0001-7176-7813
  • Valpuesta, Jose María|||0000-0001-7468-8053
  • Radford, Sheena E.|||0000-0002-3079-8039
  • Ventura, Salvador|||0000-0002-9652-6351
Oligomeric species populated during α-synuclein aggregation are considered key drivers of neurodegeneration in Parkinson's disease. However, the development of oligomer-targeting therapeutics is constrained by our limited knowledge of their structure and the molecular determinants driving their conversion to fibrils. Phenol-soluble modulin α3 (PSMα3) is a nanomolar peptide binder of α-synuclein oligomers that inhibits aggregation by blocking oligomer-to-fibril conversion. Here, we investigate the binding of PSMα3 to α-synuclein oligomers to discover the mechanistic basis of this protective activity. We find that PSMα3 selectively targets an α-synuclein N-terminal motif (residues 36-61) that populates a distinct conformation in the mono- and oligomeric states. This α-synuclein region plays a pivotal role in oligomer-to-fibril conversion as its absence renders the central NAC domain insufficient to prompt this structural transition. The hereditary mutation G51D, associated with early onset Parkinson's disease, causes a conformational fluctuation in this region, leading to delayed oligomer-to-fibril conversion and an accumulation of oligomers that are resistant to remodeling by molecular chaperones. Overall, our findings unveil a new targetable region in α-synuclein oligomers, advance our comprehension of oligomer-to-amyloid fibril conversion, and reveal a new facet of α-synuclein pathogenic mutations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CARs-DB, A Database of Cryptic Amyloidogenic Regions in Intrinsically Disordered Proteins

  • Pintado-Grima, Carlos|||0000-0002-8544-959X
  • Vilaça, Rita
  • Macedo-Ribeiro, Sandra|||0000-0002-7698-1170
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Ventura, Salvador|||0000-0002-9652-6351
  • Bárcenas, Oriol|||0000-0002-8439-4005
  • Manglano-Artuñedo, Zoe
Proteome-wide analyses suggest that most globular proteins contain at least one amyloidogenic region, whereas these aggregation-prone segments are thought to be underrepresented in intrinsically disordered proteins (IDPs). In recent work, we reported that intrinsically disordered regions (IDRs) indeed sustain a significant amyloid load in the form of cryptic amyloidogenic regions (CARs). CARs are widespread in IDRs, but they are necessarily exposed to solvent, and thus they should be more polar and have a milder aggregation potential than conventional amyloid regions protected inside globular proteins. CARs are connected with IDPs function and, in particular, with the establishment of protein-protein interactions through their IDRs. However, their presence also appears associated with pathologies like cancer or Alzheimer's disease. Given the relevance of CARs for both IDPs function and malfunction, we developed CARs-DB, a database containing precomputed predictions for all CARs present in the IDPs deposited in the DisProt database. This web tool allows for the fast and comprehensive exploration of previously unnoticed amyloidogenic regions embedded within IDRs sequences and might turn helpful in identifying disordered interacting regions. It contains.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein toxic oligomers

  • Giarola, Juliana Fatima|||0000-0002-2121-0328
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Ventura, Salvador|||0000-0002-9652-6351
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Lechuga, Laura M.|||0000-0001-5187-5358
Background: α-Synuclein (αS) aggregation is the main neurological hallmark of a group of neurodegenerative disorders, collectively referred to as synucleinopathies, of which Parkinson's disease (PD) is the most prevalent. αS oligomers are elevated in the cerebrospinal fluid (CSF) of PD patients, standing as a biomarker for disease diagnosis. However, methods for early PD detection are still lacking. We have recently identified the amphipathic 22-residue peptide PSMα3 as a high-affinity binder of αS toxic oligomers. PSMα3 displayed excellent selectivity and reproducibility, binding to αS toxic oligomers with affinities in the low nanomolar range and without detectable cross-reactivity with functional monomeric αS. Results: In this work, we leveraged these PSMα3 unique properties to design a plasmonic-based biosensor for the direct detection of toxic oligomers under label-free conditions. Significance and novelty: We describe the integration of the peptide in a lab-on-a-chip plasmonic platform suitable for point-of-care measurements of αS toxic oligomers in CSF samples in real-time and at an affordable cost, providing an innovative biosensor for PD early diagnosis in the clinic.